These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1929269)

  • 1. In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.
    Franzblau SG
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1232-4. PubMed ID: 1929269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
    Dhople AM; Dimova V
    Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA; Gardner GD
    Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of levofloxacin, singly and in combination with rifamycin analogs, against Mycobacterium leprae.
    Dhople AM; Ibanez MA
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2116-9. PubMed ID: 8540726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of BACTEC 460 TB system for measurement of in vitro anti-Mycobacterium leprae activity of various antimicrobials.
    Tomioka H; Saito H; Sato K
    Nihon Rai Gakkai Zasshi; 1992 Nov; 61(3):157-64. PubMed ID: 1308482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifabutin and rifapentine compared with rifampin against Mycobacterium leprae in mice.
    Pattyn SR
    Antimicrob Agents Chemother; 1987 Jan; 31(1):134. PubMed ID: 3032088
    [No Abstract]   [Full Text] [Related]  

  • 8. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in-vitro activities of novel benzoxazinorifamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA
    J Antimicrob Chemother; 1995 Apr; 35(4):463-71. PubMed ID: 7628981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of sitafloxacin (DU-6859a), either singly or in combination with rifampin analogs, against Mycobacterium leprae.
    Dhople AM; Namba K
    J Infect Chemother; 2003 Mar; 9(1):12-5. PubMed ID: 12673400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies of the killing of M. leprae by aminoglycosides: reduced dosage and frequency of administration.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):78-82. PubMed ID: 3549941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM; Lamoureux LC; Gardner GD
    Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
    Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages.
    Ramasesh N; Krahenbuhl JL; Hastings RC
    Antimicrob Agents Chemother; 1989 May; 33(5):657-62. PubMed ID: 2665640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of rifabutin in combination with two and three other antimicrobial agents against strains of Mycobacterium paratuberculosis.
    Chiodini RJ
    J Antimicrob Chemother; 1991 Feb; 27(2):171-6. PubMed ID: 1647388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae.
    Franzblau SG; White KE
    Antimicrob Agents Chemother; 1990 Feb; 34(2):229-31. PubMed ID: 2183714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activities of novel benzoxazinorifamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA
    Indian J Lepr; 1995; 67(4):375-82. PubMed ID: 8849914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activities of cinnamyl rifamycin derivatives, T-9 and T-11, against Mycobacterium tuberculosis and Mycobacterium avium complex (MAC) with special reference to the activities against intracellular MAC.
    Sato K; Shimizu T; Dimova V; Tomioka H
    Microbiol Immunol; 2006; 50(8):621-3. PubMed ID: 16924146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages.
    Dhillon J; Mitchison DA
    Am Rev Respir Dis; 1992 Jan; 145(1):212-4. PubMed ID: 1309967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bactericidal activity of various aminoglycoside antibiotics against Mycobacterium leprae in mice.
    Gelber RH; Henika PR; Gibson JB
    Lepr Rev; 1984 Dec; 55(4):341-7. PubMed ID: 6396475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.